SEC SETTLES CHARGES AGAINST BMW AG
FOR INACCURATE SALES DISCLOSURES IN
RULE 144
A BOND OFFERINGS
November 2020 | 3
amended (the "Exchange Act"), does not require a showing of "scienter,"
and liability under this section may be premised solely on a finding of
negligence. Therefore, the SEC had a lower burden of proof.
1
Using this lower standard, the SEC alleged that the inflated sales volume
was materially misleading even though the offering memoranda disclosed
that:
• BMW's retail vehicle sales volume data (designated as a "non-
financial key performance figure") did not correlate directly to
BMW's revenue recognition; and
• vehicles delivered for dealer use or demonstration and service
loaner vehicles were included in the retail sales data.
According to the SEC, these caveats were not sufficient because BMW
failed to disclose:
• reliance on these problematic sales practices to increase retail
sales volumes;
• the magnitude of the improper use of demonstrators and loaners;
and
• the use of the bank or the retail sales reporting calendar
modifications.
The SEC took specific issue with the use of demonstrators and loaners
solely for the purpose of artificially increasing sales numbers, without regard
to business need.
As a result, the SEC determined that the retail sales volume figures
provided to investors were misleading in violation of Sections 17(a)(2) and
17(a)(3) of the Securities Act.
Key Takeaways
The BMW enforcement action raises several key concerns that non-U.S.
issuers of Rule 144A bonds will want to consider.
• Extraterritorial reach of SEC enforcement. Case law under Rule
10b-5 presents certain limitations on the extraterritorial reach of
Rule 10b-5 for private rights of action by investors. The SEC is,
however, not constrained by this case law when it initiates
enforcement proceedings against non-U.S. issuers under Section
17(a) of the Securities Act or Rule 10b-5. As demonstrated by this
enforcement action against BMW, the reach of the U.S. securities
law may be expansive. Moreover, the recent ruling in Stoyas v.
Toshiba Corp. further highlights the potentially broad reach of U.S.
securities law liability for non-U.S. issuers, even in the context of
private rights of action brought under Rule 10b-5. For additional
information on the Toshiba case, see our recent client alert
.
1
Section 17(a), unlike Rule 10b-5, does not create a private right of action for investors.
Comparison of Section 17(a) of the Securities
Act and Rule 10b-5 of the Exchange Act
Section 17(a) of the Securities Act renders it
unlawful, in connection with the offer or sale of
any security or security-based swap agreement,
to:
• employ any device, scheme, or artifice to
defraud;
• obtain money or property by means of any
untrue statement of a material fact or any
omission to state a material fact necessary in
order to make the statements made, in light
of the circumstances under which they were
made, not misleading; or
• engage in any transaction, practice, or
course of business which operates or would
operate as a fraud or deceit upon the
purchaser.
Rule 10b-5 of the Exchange Act renders it
unlawful, in connection with the purchase or sale
of any security, to:
• employ any device, scheme, or artifice to
defraud;
• make any untrue statement of a material fact
or to omit to state a material fact necessary in
order to make the statements made, in the
light of the circumstances under which they
were made, not misleading; or
• engage in any act, practice, or course of
business which operates or would operate as
a fraud or deceit upon any person.
Violations of Sections 17(a)(2) and (a)(3) do not
require "scienter" and may be premised on a
finding of negligence. In contrast, courts have
interpreted Rule 10b-5 to require scienter and,
accordingly, negligent conduct is insufficient to
create liability under the rule. Scienter in this
context means the
intent on the part of the
defendant to deceive, manipulate or defraud.
Reckless conduct, however, may nevertheless
meet the scienter requirement, though the
degree of recklessness may vary by court.
While the U.S. Supreme Court has not opined
on whether reckless conduct meets the
scienter requirement under Rule 10b-5, many
courts have interpreted Rule 10b-5 as
extending liability to such conduct.